AzTrials
AzTrials

Autism Spectrum DisorderIMPRESSIVENCT04771338

Examining the Effects of a Job Entry Intervention

A study testing VR-JIT/KF-STRIDE in people with Autism Spectrum Disorder and Autism, run by Kessler Foundation at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The current study will examine the efficacy of a virtual reality (VR) intervention as well as a newly developed Kessler Foundation STRength IDentification and Expression tool (VR-STRIDE) with adolescents diagnosed with autism spectrum disorder. Read more about this study

Who is it for?
Ages 15 to 24 yearsHealthy volunteers can take part
Conditions the study is for
Autism Spectrum Disorder, Autism, ASD
What is being tested?
VR-JIT/KF-STRIDE
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteUnited States
Study dates
1 Sep 2019to 26 Jul 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 24 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Diagnoses of ASD
  • or am a typically developing adolescent
  • Able to speak and read English fluently

Who cannot join

  • History of stroke, traumatic brain injury, or any other neurological injury or disease
  • History of significant psychiatric illness (bipolar, schizophrenia or psychosis)
  • Uncontrolled seizures
  • Any other unstable medical complications

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Kessler Foundation

    East Hanover, New Jersey, 07936

Other trials in United States

About this study

The current study will examine the efficacy of a virtual reality (VR) intervention as well as a newly developed Kessler Foundation STRength IDentification and Expression tool (VR-STRIDE) with adolescents diagnosed with autism spectrum disorder.

Read the detailed description

The current study will examine the efficacy of a virtual reality (VR) intervention entitled "IMPRoving Expression of Skills and Strengths In Interviewing in a Virtual Environment" (IMPRESSIVE) which targets social competency skills needed for successful job interviewing. Specifically, 2 VR tools are utilized in the IMPRESSIVE intervention. The first tool is VR-Job Interview Training, a VR program which offers the opportunity for repeated practice with a virtual human interviewer. Preliminary evidence suggests that the VRprogram is successful in adults with ASD and schizophrenia in improving interview abilities. However, the efficacy of it has not been evaluated in adolescents with ASD. This represents a significant void in our knowledge, as we do not know whether this program is effective for youth. In addition to VR training, a newly developed tool is included in the currently proposed intervention: the Kessler Foundation STRength IDentification and Expression tool (VR-STRIDE). KF-STRIDE is focused on improving the ability to express personal strengths during the job interview, a skill that is not taught with VR training. The proposed IMPRESSIVE intervention, which combines the learning of 2 critical abilities (social skills and strength identification), has never been examined in individuals with ASD. Thus, the current proposal will be the first to examine the efficacy of these 2 combined tools in this at-risk population.

Being tested
VR-JIT/KF-STRIDE
Keywords
Autism, ASD, Job reentry, Employment intervention, Virtual reality, VR
Medical subject headings
Autism Spectrum Disorder, Autistic Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VR-JIT/KF-STRIDEBehavioural

    Also called Virtual Interview Training for Transition Age Youth (VIT-TAY), Kessler Foundation STRength IDentification and Expression tool (KF-STRIDE)

    Treatment group will receive 12 sessions of job interview training protocol.

Study groups in NCT04771338
Study groupRoleWhat they receive
Treatment groupExperimentalJob interview training protocol for 12 sessions
Receives: Behavioral: VR-JIT/KF-STRIDE
Control groupNo interventionNo participation in any intervention protocol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mock Job Interview Change

    Mock Job Interview skills will be assessed by having blinded raters trained to assess job interviews scoring participants across a number of domains including expressing personal strengths and sounding professional. This rating scheme has been used in previous research (Smith et al., 2014; 2015),

    Measured: 8 weeks

Secondary outcomes (4)
  1. Self-reported job interview skills

    Questionnaire to assess self-perceived skills

    Measured: 8 weeks

  2. self-reported job interview anxiety

    Questionnaire to assess self-perceived anxiety

    Measured: 8 weeks

  3. Employment readiness

    Questionnaire to assess self-perceived employment readiness

    Measured: 8 weeks

  4. Job Search Behavior

    Questionnaire to assess self-perceived job search behaviors

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Feb 2021
  2. Study start1 Sep 2019
  3. Primary completion22 Jun 2022
  4. Study completion26 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Model description
Virtual Reality Job Interview Training \& character strength training (KF-STRIDE)
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04771338
Sponsor's protocol ID
R-1078-19
Acronym
IMPRESSIVE
Status last verified
Jan 2024
First submitted
23 Feb 2021
Last updated
17 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing VR-JIT/KF-STRIDE in people with Autism Spectrum Disorder and Autism, run by Kessler Foundation at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mock Job Interview Change (time frame: 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in